Sherwin-Williams Co (NYSE:SHW) (Full FREE Analysis of SHW And Be Sure To Notice The Intermediate Period) reported that its outlook for FY14 (Dec), narrows EPS to $8.75-8.80 from $8.70-8.80, might not be similar to $8.83 Capital IQ Consensus. The firm expects FY14 (Dec) revs +9% (from +9-11%) to $11.1B as compare to $11.18B Capital IQ Consensus Estimate. Whereas, shares of Sherwin-Williams Co (NYSE:SHW) traded down of -2.74% to finished at USD247.24 with market capitalization of 23.61 billion. Separately, a research note to investors, 11 analysts rates its stocks at “Hold,” 3 analysts rate it at “strong buy” and 7 rate it a “Buy.”
Windstream Holdings, Inc. (NASDAQ:WIN) (Read Latest Free Analytic Facts on WIN and Be Updated) released on Friday that that Bob Gunderman has been hired CFO for the company, effective immediately. The firm reported that that Bob Gunderman has been hired CFO for the firm, effective immediately. Gunderman has been serving as interim CFO since Oct. 1, 2014. Share price of Windstream Holdings, Inc. (NASDAQ:WIN) fell -9.70% to close at $8.47 with the traded volume of 21.30 million shares as compared to the average volume of 6.20 million in last session. The 12 analysts rate its stocks at “Hold,” 1 analyst rates it at “strong buy” and 2 rate it a “underperfrom,” according to a recent a pool of analysts rating.
Oncothyreon Inc (USA) (NASDAQ:ONTY) (Read Experts View Here on ONTY Upcoming Performance) released that its presentation of optimistic ONT-380 Data at San Antonio Breast Cancer Symposium; Phase 1 data demonstrate preliminary clinical activity and tolerability in heavily pretreated patient population. As, Oncothyreon Inc (USA) (NASDAQ:ONTY) has 0.88 beta factor with last traded share price of $2.02 with positive change of 18.13%. On analytic notes; diverse intension of analysts reflects as, 1 analyst rates its stocks at “Hold,” 1 analyst rates it at “strong buy” and 2 rate it a “Buy.”
MEI Pharma Inc (NASDAQ:MEIP) (What Market Forces Produce Volatility in MEIP Share? Find Free Report Here) released on Friday that it has priced an underwritten public offering of 10M shares of its common stock at an proposing price of $4 a share, for total gross proceeds, before underwriting discount as well as commissions and estimated costs, of around $40M. MEI Pharma Inc (NASDAQ:MEIP) stock fell -0.12% to close at $4.20 with the total traded volume of 3.10 million shares.
For latest Market Updates Subscribes Here
